Age of Onset of Receptor Tyrosine Kinase Fusions Drives Distinct Biologic Outcomes in Thyroid Cancer

被引：4
|
作者：
Fagin, James A. [1 ,2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Weill Cornell Med Coll, Dept Med, 1275 York Ave, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Weill Cornell Med Coll, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10065 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 10期
关键词：
REARRANGEMENTS; CARCINOMA; CHILDREN;
D O I：
10.1200/JCO.21.02864
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1124 / +
页数：4
相关论文
共 50 条
  • [31] Aerodigestive Fistula Formation as a Rare Side Effect of Antiangiogenic Tyrosine Kinase Inhibitor Therapy for Thyroid Cancer
    Blevins, Dean P.
    Dadu, Ramona
    Hu, Mimi
    Baik, Christina
    Balachandran, Diwakar
    Ross, William
    Gunn, Brandon
    Cabanillas, Maria E.
    THYROID, 2014, 24 (05) : 918 - 922
  • [32] Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
    Kurzrock, Razelle
    Sherman, Steven I.
    Ball, Douglas W.
    Forastiere, Arlene A.
    Cohen, Roger B.
    Mehra, Ranee
    Pfister, David G.
    Cohen, Ezra E. W.
    Janisch, Linda
    Nauling, Forlisa
    Hong, David S.
    Ng, Chaan S.
    Ye, Lei
    Gagel, Robert F.
    Frye, John
    Mueller, Thomas
    Ratain, Mark J.
    Salgia, Ravi
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (19) : 2660 - 2666
  • [33] Advanced non-Small cell lung cancer patients at the extremes of age in the era of epidermal growth factor receptor tyrosine kinase inhibitors
    Chen, Yu-Mu
    Lai, Chien-Hao
    Rau, Kun-Ming
    Huang, Cheng-Hua
    Chang, Huang-Chih
    Chao, Tung-Ying
    Tseng, Chia-Cheng
    Fang, Wen-Feng
    Chen, Yung-Che
    Chung, Yu-Hsiu
    Wang, Yi-Hsi
    Su, Mao-Chang
    Huang, Kuo-Tung
    Liu, Shih-Feng
    Chen, Hung-Chen
    Chang, Ya-Chun
    Chang, Yu-Ping
    Wang, Chin-Chou
    Lin, Meng-Chih
    LUNG CANCER, 2016, 98 : 99 - 105
  • [34] Are tyrosine kinase inhibitors as effective as they are safe in renal cell cancer patients over the age of 65?
    Ulas, Arife
    Kos, Fahriye Tugba
    Dede, Didem Sener
    Yalcin, Bulent
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2022, 13 (01): : 45 - 49
  • [35] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Squamous Cell Lung Cancer
    Xu, Jianlin
    Chu, Tianqing
    Jin, Bo
    Dong, Xue
    Lou, Yuqing
    Zhang, Xueyan
    Wang, Huiming
    Zhong, Hua
    Shi, Chunlei
    Gu, Aiqing
    Xiong, Liwen
    Zhao, Yizhuo
    Jiang, Liyan
    Zhang, Jie
    Han, Baohui
    CLINICAL LUNG CANCER, 2016, 17 (04) : 309 - 314
  • [36] Prognostic value of receptor tyrosine kinase-like orphan receptor (ROR) family in cancer: A meta-analysis
    Saleh, Ramy R.
    Fuentes Antras, Jesus
    Peinado, Paloma
    Perez-Segura, Pedro
    Pandiella, Atanasio
    Amir, Eitan
    Ocana, Alberto
    CANCER TREATMENT REVIEWS, 2019, 77 : 11 - 19
  • [37] The Receptor Tyrosine Kinase TrkA Is Increased and Targetable in HER2-Positive Breast Cancer
    Griffin, Nathan
    Marsland, Mark
    Roselli, Severine
    Oldmeadow, Christopher
    Attia, John
    Walker, Marjorie M.
    Hondermarck, Hubert
    Faulkner, Sam
    BIOMOLECULES, 2020, 10 (09) : 1 - 13
  • [38] Outcome of Patients with Locally Advanced Metastatic Medullary Thyroid Cancer and Induction Therapy with Tyrosine Kinase Inhibitors in Slovenia
    Grasic Kuhar, Cvetka
    Lozar, Taja
    Besic, Nikola
    Music Marolt, Maja
    ADVANCES IN THERAPY, 2021, 38 (12) : 5684 - 5699
  • [39] Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects
    Puliafito, Ivana
    Esposito, Francesca
    Prestifilippo, Angela
    Marchisotta, Stefania
    Sciacca, Dorotea
    Vitale, Maria Paola
    Giuffrida, Dario
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [40] Treatment of anaplastic thyroid cancer with tyrosine kinase inhibitors targeted on the tumor vasculature: initial experience in clinical practice
    Ishihara, Sae
    Onoda, Naoyoshi
    Noda, Satoru
    Tauchi, Yukie
    Morisaki, Tamami
    Asano, Yuka
    Kashiwagi, Shinichiro
    Takashima, Tsutomu
    Ohira, Masaichi
    ENDOCRINE JOURNAL, 2021, 68 (01) : 63 - 68
12345